2019 Fall Policy Summit
"The Texas Life Science Landscape"
THBI is the leading health policy voice in the state, influencing legislation that has led to economic investment and medical breakthroughs for over 20 years. Join us November 7th and be a part of the conversations on The Texas Life Science Landscape. This is your opportunity to be in front of key decision makers and leaders in our industry.
Sponsorships are going fast - be sure to email email@example.com to secure your sponsorship opportunity. Networking opportunities, lunch sponsorships, and panel sponsorships are all available. Click here to see a comprehensive list of sponsorship benefits.
The Summit will include key networking opportunities with pharmaceutical companies, academic institutions, biotech and medical device companies, economic development entities, patients, and service providers. Panels and keynote discussions will feature topics such as:
"The Impact of Regulation on Your Bottom Line: Good vs. Bad policy ideas"
The life science industry is ever changing and ever evolving. This discussion will focus on good ideas and bad ideas that state and federal lawmakers enact and the regulations that impact the industry's ability to continue thriving. Exploring the impacts of regulation on innovation, research and development, and academic research.
"Commercialization in Today's Economic Environment."
Industry in the state of Texas strives to create commercialization relationships and initiatives that can expand the economic base of biosciences and technology throughout the entire state and nation. Join the conversation as pharmaceutical executives, academic researchers, economic development entities and service providers discuss how commercialization can steer the direction of the life science industry towards the future.
"Drug Pricing, Security, and the Impact of Importation"
Importation schemes have been proposed at various times as an approach to reducing drug costs. This discussion will focus on the impact that drug importation has on patient's health and safety, how these policies impact the industry as a whole and their ability to sustain patient's access to their medications. Further explore how the industry is managing the research, development, and manufacturing of innovative drugs and therapies in light of drug importation policies.